Baotai Liang
Clinical trials sponsored by Baotai Liang, explained in plain language.
-
New drug combo aims to shrink tough prostate cancers before surgery
Disease control Recruiting nowThis study tests whether adding the drug homoharringtonine to standard hormone therapy before prostate removal can improve outcomes for men with high-risk or advanced prostate cancer. About 93 participants will receive the combination before surgery. The goal is to see if this ap…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New drug cocktail aims to wipe out prostate cancer before surgery
Disease control Recruiting nowThis study tests whether adding two drugs (fasudil hydrochloride and a PD1 inhibitor) to standard hormone therapy can better shrink prostate cancer before surgery. About 83 men with locally advanced or limited spread prostate cancer will take part. The goal is to see if this comb…
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Could a leukemia drug boost prostate cancer treatment?
Disease control Recruiting nowThis study tests whether adding the drug homoharringtonine to standard hormone therapy before prostate removal surgery can better shrink or eliminate tumors in men with locally advanced or limited-spread prostate cancer. About 96 men will receive either the combination or hormone…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New combo therapy aims to control hard-to-treat prostate cancer
Disease control Recruiting nowThis study tests whether adding fasudil hydrochloride to immunotherapy can help control metastatic castration-resistant prostate cancer in patients who have already tried standard treatments. About 30 adults aged 18 to 85 will receive the combination therapy. Researchers will mea…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC